Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy
Status:
COMPLETED
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Patients aged 35 to 70 years with newly diagnosed stage 1 or 2 hypertension ( HTN) was randomized to receive either Valsartan 80 mg/Amlodipine 5 mg fix dose combination (FDC) or a free equivalent combination. Ambulatory blood pressure monitoring at baseline and 8 weeks post-treatment initiation was performed.
Phase:
PHASE4
Details
Lead Sponsor:
Shiraz University of Medical Sciences
Treatments:
Amlodipine Amlodipine, Valsartan Drug Combination Valsartan